XML 50 R31.htm IDEA: XBRL DOCUMENT
v3.4.0.3

Acquisitions (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2016
DenTek Oral Care, Inc. |
Business Acquisition [Line Items] |
Purchase Price Allocation | The following table summarizes our preliminary allocation of the assets acquired and liabilities assumed as of the February 5, 2016 acquisition date.
(In thousands) | February 5, 2016
Cash acquired | $ | 1,359 |
Accounts receivable | 9,187 |
Inventories | 14,304 |
Deferred income taxes | 3,303 |
Prepaids and other current assets | 6,728 |
Property, plant and equipment, net | 3,555 |
Goodwill | 76,529 |
Intangible assets, net | 206,700 |
Total assets acquired | 321,665 |
Accounts payable | 3,261 |
Accrued expenses | 16,488 |
Deferred income tax liabilities - long term | 73,573 |
Total liabilities assumed | 93,322 |
Total purchase price | $ | 228,343 |
Insight Pharmaceuticals Corporation |
Business Acquisition [Line Items] |
Purchase Price Allocation | The following table summarizes our allocation of the assets acquired and liabilities assumed as of the September 3, 2014 acquisition date, after giving effect of the adjustments noted above.
(In thousands) | September 3, 2014
Cash acquired | $ | 3,507 |
Accounts receivable | 26,012 |
Inventories | 23,456 |
Deferred income tax assets - current | 1,032 |
Prepaids and other current assets | 1,341 |
Property, plant and equipment | 2,308 |
Goodwill | 96,323 |
Intangible assets | 724,374 |
Total assets acquired | 878,353 |
Accounts payable | 16,079 |
Accrued expenses | 8,539 |
Deferred income tax liabilities - long term | 107,799 |
Total liabilities assumed | 132,417 |
Total purchase price | $ | 745,936 |
Pro Forma Information | The following table provides our unaudited pro forma revenues, net income and net income per basic and diluted common share had the results of Insight's operations been included in our operations commencing on April 1, 2013, based upon available information related to Insight's operations. This pro forma information is not necessarily indicative either of the combined results of operations that actually would have been realized by us had the Insight acquisition been consummated at the beginning of the period for which the pro forma information is presented, or of future results.
| Year Ended March 31,
| 2015 |  | 2014
(In thousands, except per share data) | (Unaudited)
Revenues | $ | 783,217 |  |  | $ | 767,897 |
Net income | $ | 86,844 |  |  | $ | 82,762 |
Earnings per share: |  |  |
Basic | $ | 1.66 |  |  | $ | 1.60 |
Diluted | $ | 1.65 |  |  | $ | 1.58 |
Hydralyte |
Business Acquisition [Line Items] |
Purchase Price Allocation | The following table summarizes our allocation of the assets acquired and liabilities assumed as of the April 30, 2014 acquisition date.
(In thousands) | April 30, 2014
Inventories | $ | 1,970 |
Property, plant and equipment, net | 1,267 |
Goodwill | 1,224 |
Intangible assets, net | 73,580 |
Total assets acquired | 78,041 |
Accrued expenses | 38 |
Other long term liabilities | 12 |
Total liabilities assumed | 50 |
Net assets acquired | $ | 77,991 |
Care Pharma |
Business Acquisition [Line Items] |
Purchase Price Allocation | The following table summarizes our allocation of the assets acquired and liabilities assumed as of the July 1, 2013 acquisition date.
(In thousands) | July 1, 2013 |
Cash acquired | $ | 1,546 |
Accounts receivable | 1,658 |
Inventories | 2,465 |
Deferred income tax assets | 283 |
Prepaids and other current assets | 647 |
Property, plant and equipment | 163 |
Goodwill | 23,122 |
Intangible assets | 31,502 |
Total assets acquired | 61,386 |
Accounts payable | 1,537 |
Accrued expenses | 2,788 |
Other long term liabilities | 300 |
Total liabilities assumed | 4,625 |
Net assets acquired | $ | 56,761 |

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionProFormaInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=pbh_DenTekOralCareInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=pbh_InsightPharmaceuticalsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=pbh_HydralyteMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=pbh_CarePharmaceuticalsPtyLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |